Vice President

Company Overview:

Beam Therapeutics is committed to establishing the leading, fully integrated platform for precision genetic medicines. To achieve this vision, Beam has assembled a platform that includes a suite of gene editing and delivery technologies and is in the process of building internal manufacturing capabilities. Beam’s suite of gene editing technologies is anchored by base editing, a proprietary technology that is designed to enable precise, predictable and efficient single base changes, at targeted genomic sequences, without making double-stranded breaks in the DNA. This has the potential to enable a wide range of potential therapeutic editing strategies that Beam is using to advance a diversified portfolio of base editing programs. Beam is a values-driven organization committed to its people, cutting-edge science, and a vision of providing life-long cures to patients suffering from serious diseases.

Position Overview:

Beam is looking for a highly motivated, strategic, and collaborative leader to join our growing Commercial team.  The VP, Patient Operations, will shape the strategy, build and oversee the execution of patient scheduling and apheresis operations, including leading the selection and implementation of a cell therapy orchestration platform.  The focus in the short- to mid-term will be on BEAM-101, an ex vivo autologous hematopoietic stem cell-based gene therapy for the treatment of severe sickle cell disease (SCD).  Patient Operations will be critical for the provider and patient experience and as such, this role will be a crucial member of the cross-functional team preparing for Beam’s potential first product commercialization.  Additionally, will be responsible in thinking long term in scale to incorporate Beam’s next-generation hematology programs which have the potential to address significantly more patients.  The successful candidate will also help shape the strategy for commercial patient supply for our in vivo genetic medicines products.

Responsibilities:

• Define strategy for Patient Operations, including patient scheduling rules, manufacturing slot allocation, and exception management
• Partner with Manufacturing, Supply Chain, Quality, Regulatory, IT and others to ensure scalable processes for patient scheduling and apheresis operations that meet both Beam’s business needs and ensure a positive patient and provider treatment experience
• Provide strategic and operational leadership to the implementation of a cell therapy orchestration platform and integration into other systems to enable functions such as patient registration and scheduling, chain of identity / chain of custody (COI/COC) traceability, order management, inbound and outbound cell logistics etc.   
• Define organizational needs to onboard and support apheresis operations at treatment centers
• Build and manage teams to execute patient scheduling and apheresis operations

Qualifications:

• BS/BA in a relevant academic field; MBA, MD, PhD, or other graduate degree strongly preferred with 20+ years experience within the pharma/biotech/biopharma space in roles of progressively increasing responsibility.
• Experience in gene and/or cell therapy strongly desired, particularly in autologous cell therapy.
• Sophisticated understanding of the operational complexity and evolving scientific, clinical, regulatory, competitive, and economic trends in the cell / gene therapy industry, and able to adapt operational strategies accordingly.
• Proven track record in cross-functional leadership role or other cross-disciplinary background with successful team leadership experience required.
• Exceptional interpersonal skills and collaborative nature with strong ability to influence, motivate, inspire, encourage and develop others.
• Driven by patient needs and comfortable operating in a highly complex and technical environment while dealing with ambiguity.
• Experience with U.S. commercialization preferred.
• Experience in both large and small company environments a plus.